Welcome to the ECFS Board Elections 2024

The following information is to guide you through the election process.

Open positions for election:

3 Board Members

Election period:

23 May, 17:00 CEST
3 June, 17:00 CEST

The 2024 Elections are now CLOSED

How to vote?

Log in to myECFS and open the webform for the Board members elections.
 

Eligible voters:

Active ECFS Members as of 17 May 2024 can vote in the elections


Article 3 of the ECFS Constitution on Membership


Dear ECFS Members,


The European Cystic Fibrosis Society Board has three vacancies this year. Prof. Barry Plant and Dr. Pavel Drevinek finish their terms and we wish to express our deepest thanks to both for their contribution to the Board over the past 6 years. Prof. Isabelle Fajac will end her tenure as ECFS President this coming June and we are very grateful for her leadership, especially during the difficult years of the COVID-19 pandemic.


We have received nominations for three senior figures of the CF community.
Please see their nominations, CV and personal statements here below.


This year, we are in the unusual position of having received three applications for the three open positions. Under these unusual circumstances, it was felt it would not be a sensible use of our resources to organise secured online elections.


In our constitution, and in the interest of democracy, we do require to have a vote on the three candidates’ applications. There is an opportunity if anyone wishes to express a NO vote to any of them in the anonymous webform: https://www.ecfs.eu/ecfs-board-elections-2024-form available when logged in to myecfs.  The form will remain available until 3 June 23:59 CEST.


It is very important for us in the Society to clearly express our support for those elected and appointed to lead the Society and we would be very grateful if you would take the time to express your opinion on the three candidates’ applications.


Many thanks,


looking forward to seeing you all soon in Glasgow, 


Silke van Koningsbruggen-Rietschel
ECFS Secretary

ECFS Board Members

Members of the ECFS Board serve an important role within the organisation. The current responsibilities and future development of the Society are ensured through the active participation of its Board. There are significant expectations of involvement, participation, support and commitment to the Society’s mission.

Board Members - Candidates

 

Jürg Barben

Jürg Barben is head of the Paediatric CF Centre in St. Gallen, responsible for the care of all children with CF from Eastern Switzerland. He is involved in daily care and clinical research. He has published over 40 papers on neonatal screening, CFSPID and sweat testing. As president of the Swiss Working Group for CF (2006-2014), he introduced CF neonatal screening in Switzerland. For two decades, he has been actively involved in ECFS activities in the Diagnostic Network (DNWG) and Neonatal Screening Working Group (NSWG). In 2019, he became leader of the ECFS NSWG, organising meetings and producing a book and six papers. From his work with the society and previously as CF Lead for the European Respiratory Society (ERS), he has a global view of CF care, independent of pharma support, and strongly advocates of equal access to drugs for all pwCF.

Nominations
Application
CV

 

Pierre-Regis Burgel

Pierre-Régis Burgel is Professor of Respiratory Medicine at Cochin Hospital/Université Paris Cité, France. He is President of the French CF Society, an associate editor of the Journal of Cystic Fibrosis, and member of the ECFS patient registry scientific committee. Over the past years he has participated to multiple ECFS task forces and to the ECFS standard of care. Current research interests include real-world evaluation of CFTR modulators in F508del and non-F508del people with CF and translational research programs in adults with CF.

Nominations
Application
CV

 

Charles Haworth

Charles Haworth is a consultant at Royal Papworth Hospital, Cambridge, UK where he specialises in treating adults with CF, bronchiectasis and NTM infections. He was senior author of the ECFS Bone Health guidelines (2011) and the ECFS / CFF NTM guidelines (2015). He was a member of the EC funded “Inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis” consortium and is a Principal Investigator within the ECFS Clinical Trials Network. He was an executive committee member of the UK CF Medical Association 2018-2021.

Nominations
Application
CV

 

Board composition 2023-2024 – Elected members

Isabelle Fajac, FR – ending second mandate
Jane Davies, UK 
Pavel Drevinek, CZ  – ending second mandate
Carlos Farinha, PT
Barry Plant, IE – ending second mandate
Dorota Sands, PL
Carsten Schwarz, DE 
Silke van Koningsbruggen-Rietschel, DE